No Data
No Data
Lake Street Maintains Arcadia Biosciences(RKDA.US) With Buy Rating, Maintains Target Price $12
Lake Street analyst Ben Klieve maintains $Arcadia Biosciences(RKDA.US)$ with a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 44.9% and
Optimizing Growth: Arcadia Biosciences' Strategic Divestitures and Expanding Market Share
H.C. Wainwright Maintains Arcadia Biosciences(RKDA.US) With Buy Rating, Cuts Target Price to $6
H.C. Wainwright analyst Ram Selvaraju maintains $Arcadia Biosciences(RKDA.US)$ with a buy rating, and adjusts the target price from $10 to $6.According to TipRanks data, the analyst has a success rate
Arcadia Biosciences Is Maintained at Buy by HC Wainwright & Co.
Arcadia Biosciences Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6
Arcadia Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/23/2024 100% HC Wainwright & Co. $10 → $6 Maintains Buy 04/05/2024 233.33% HC Wainwright & Co. → $10 Re
No Data